Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol.
The decision for PJP prophylaxis depends on a physician's evaluation of multiple variables. The high rate of PJP infection described in this article combined with the known impaired T-cell function post Bendamustine treatment justifies considering all patients for PJP prophylaxis when they receive Bendamustine treatment.
Department of Haematology, University Hospital Limerick Limerick, Ireland.
Tarig Mohammed
TM
Abkur
Department of Haematology, University Hospital Limerick Limerick, Ireland.
Mamoun
M
Saeed
Department of Haematology, University Hospital Limerick Limerick, Ireland.
Saad Zeinalabdin
SZ
Ahmed
Graduate Entry Medical School, University of Limerick Limerick, Ireland.
Ryan
R
McArthur
Department of Haematology, University Hospital Limerick Limerick, Ireland ; Graduate Entry Medical School, University of Limerick Limerick, Ireland.
Maeve
M
Leahy
Department of Haematology, University Hospital Limerick Limerick, Ireland ; Graduate Entry Medical School, University of Limerick Limerick, Ireland.
Hilary
H
O'Leary
Department of Haematology, University Hospital Limerick Limerick, Ireland ; Graduate Entry Medical School, University of Limerick Limerick, Ireland.
Denis
D
O'Keeffe
Bendamustine; Pneumocystis; Trimethoprim/Sulfamethoxazole